Socio-medical aspects of the normalization of body mass
https://doi.org/10.14341/omet2016449-52
Abstract
Increased body mass index (BMI) in today's world has become one of the most common and extremely dangerous to humanity diseases. The expansion of fast food chains, high-calorie food, sedentary lifestyle, stress, accumulation of population in cities – the main causes of overweight. In the twenty-first century, in scientific literature introduced a new term "globesity", reflecting the global nature of global problems. However, studies in recent years, several break this logic: "overweight – obesity – the risk of chronic diseases – the risk of premature death." Often, those with elevated BMI have a greater life expectancy than patients with normal or decreased BMI. The latter causes the appearance of a new term "obesity paradox". Indeed, increased BMI significantly reduces the quality of life, increases the risk of social problems. Persons suffering from increased BMI, harder to find a job and to arrange his personal life. In the United States of America the presence of increased body mass index (BMI) results in a significant rise in the cost of health insurance. Reducing excess weight is completely dependent on patients who need along with medication to live a healthy lifestyle. An important direction of minimize obesity and its consequences seem to be a diet, refusal of personal transport, leisure, vacation travel. American society of specialists in the field of metabolic and bariatric surgery define obesity as a chronic, relapsing, multifactorial neurobehavioral disorder in which the increase of fat in the body contributes to the dysfunction of adipose tissue with the development of threat for physical and psychological health of the metabolic and psychosocial consequences.
About the Authors
Irina Leskova
Russian State Social University
Russian Federation
Doctor of Social Sciences, prof.
Russian Federation
Doctor of Social Sciences, prof.
Dmitriy Ermakov
Finance University under the Government of the Russian Federation
Russian Federation
ScD, prof.
Russian Federation
ScD, prof.
Elena Matushevskaya
Harvard University
United States
PhD, prof.
United States
PhD, prof.
Ol'ga Nishnianidze
Southwest State University
Russian Federation
PhD
Russian Federation
PhD
References
1. Берштейн Л.М. Диабет, ожирение и онкологическая заболеваемость: риски и антириски // Сахарный диабет. – 2012. – Т. 15. – №4 – C. 81-88. [Bershteyn LM. Diabetes, obesity and cancer: risk and anti-risk factors. Diabetes mellitus. 2012;15(4):81-88. (In Russ)] doi: 10.14341/2072-0351-5543
2. ВОЗ. Ожирение, избыточный вес. Официальный сайт Всемирной организации здравоохранения. Available at: http://www.who.int/mediacentre/factsheets/fs311/ru/.
3. Вознесенская Т.Г.Расстройства пищевого поведения при ожирении их коррекция // Ожирение и метаболизм. – 2004. – Т. 1. – №2 – C. 2-6. [Voznesenskaya TG. Rasstroystva pishchevogo povedeniya pri ozhireniii ikh korrektsiya. Obesity and metabolism. 2004;1(2):2-6. (In Russ)] doi: 10.14341/2071-8713-4893
4. Дедов И.И., Мельниченко Г.А., Бутрова С.А., и др. Ожирение у подростков в России // Ожирение и метаболизм. – 2006. – Т. 3. – №4 – C. 30-34. [Dedov II, Mel'nichenko GA, Butrova SA, et al. Ozhirenie u podrostkov v Rossii. Obesity and metabolism. 2006;3(4):30-34. (In Russ)] doi: 10.14341/2071-8713-5141
5. Дедов И.И., Шестакова М.В. Инкретины: новая веха в лечении сахарного диабета 2-типа. Практическое руководство для врачей. / – М.: Дипак; 2010. [Dedov II, Shestakova MV. Inkretiny: novaya vekha v lechenii sakharnogo diabeta 2-tipa. Prakticheskoe rukovodstvo dlya vrachey. Moscow: Dipak; 2010. (In Russ)].
6. Дедов И.И., Мельниченко Г.А. Эндокринология. Национальное руководство. – М.: Гэотар-Медиа; 2008. [Dedov II, Mel'nichenko GA. Endokrinologiya. Natsional'noe rukovodstvo. Moscow: Geotar-Media; 2008. (In Russ)].
7. Игнатьева Е.В., Афонников Д.А., Рогаев Е.И., Колганов Н.А. Гены, контролирующие пищевое поведение и массу тела человека, их функциональные и геномные характеристики // Вавиловский журнал генетики и селекции. – 2014. – Т.18. – № 4/2. – C. 867-875. [Ignat'eva EV, Afonnikov DA, Rogaev EI, Kolganov NA. Geny, kontroliruyushchie pishchevoe povedenie i massu tela cheloveka, ikh funktsional'nye i genomnye kharakteristiki. Vavilovskiy zhurnal genetiki i selektsii. 2014;18(4/2):867-875. (In Russ)]
8. Институт земли: рейтинг стран мира по уровню счастья населения в 2016 году. Available at: http://gtmarket.ru/news/2016/03/17/7295
9. Картелишев А.В. Румянцев А.Г., Смирнова Н.С. Ожирение у детей и подростков. Причины и современные технологии терапии и профилактики. – М.: Бином; 2013. [Kartelishev AV, Rumyantsev AG, Smirnova NS. Ozhirenie u detey i podrostkov. Prichiny i sovremennye tekhnologii terapii i profilaktiki. Moscow:Binom; 2013. (In Russ)]
10. Лескова И.В., Шалашникова В.Ю. Семейный бизнес: преимущества и недостатки // Актуальные проблемы социально-гуманитарных и научно-технических знаний. – 2016. – №1 (6). – С. 49-51. [Leskova IV. Shalashnikova VY. Semeynyy biznes: preimushchestva i nedostatki. Aktual'nye problemy sotsial'no-gumanitarnykh i nauchno-tekhnicheskikh znaniy. 2016;1 (6):49-51 (In Russ)]
11. Передерий В.Г., Ткач С.М., Кутовой В.М., Роттер М.Н. Избыточный вес и ожирение. Монография. — Киев: Старт-98; 2013. [Perederiy VG, Tkach SM, Kutovoy VM, Rotter MN. Izbytochnyy ves i ozhirenie. Monografiya. Kiev: Start-98; 2013. (In Russ)].
12. Путин сказал, сколько в 2016 году потратят на медицину. Газета труд. Available at:http://www.trud.ru/article/07-09-2015/1328717_putin_skazal_skolko_v_2016_godu_potratjat_na_meditsinu.html
13. Самородская И.В., Болотова Е.В., Бойцов С.А. Актуальные вопросы классификации ожирения //Кардиоваскулярная терапия и профилактика. – 2015. – Т. 14. – №. 4. – С. 103-110. [Samorodskaya IV, Bolotova EV, Boytsov SA. Aktual'nye voprosy klassifikatsii ozhireniya. Kardiovaskulyarnaya terapiya i profilaktika. 2015;14(4):103-110. (In Russ)]
14. Самородская И.В. Ожирение: оценка и тактика ведения / Под ред. Самородская И.В. – Санкт-Петербург: СпецЛит; 2016. [Samorodskaya IV. Ozhirenie: otsenka i taktika vedeniya. Ed. by Samorodskaya IV. Saint-Petersburg: SpetsLit; 2016. (In Russ)]
15. Тельнова М.Э. Метаболические, гормональные, психические особенности ожирения у молодых мужчин с дебютом заболевания в детском и подростковом возрасте: Дис. ... канд. мед. наук. – Москва; 2014. [Tel'nova ME. Metabolicheskie, gormonal'nye, psikhicheskie osobennosti ozhireniya u molodykh muzhchin s debyutom zabolevaniya v detskom i podrostkovom vozraste. [dissertation] Moscow; 2014 (In Russ)]
16. Amori RE, Lau J, Pittas AG. Efficacy and Safety of Incretin Therapy in Type 2 Diabetes. Jama. 2007;298(2):194. doi: 10.1001/jama.298.2.194.
17. Aronoff SL, Berkowitz K, Shreiner B, Want L. Glucose Metabolism and Regulation: Beyond Insulin and Glucagon. Diabetes Spectrum. 2004;17(3):183-190. doi: 10.2337/diaspect.17.3.183.
18. Astrup A, Rössner S, Van Gaal L, et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. The Lancet. 2009;374(9701):1606-1616. doi: 10.1016/s0140-6736(09)61375-1.
19. Bray GA. Contemporary diagnosis and management of obesity and the metabolic syndrome. Third ed. Newtown, PA: Handbooks in Health Care, 2003.
20. Dixon JB, Dixon ME, O'Brien PE. Depression in Association With Severe Obesity. Archives of Internal Medicine. 2003;163(17):2058. doi: 10.1001/archinte.163.17.2058.
21. Dockray S, Susman EJ, Dorn LD. Depression, Cortisol Reactivity, and Obesity in Childhood and Adolescence. Journal of Adolescent Health. 2009;45(4):344-350. doi: 10.1016/j.jadohealth.2009.06.014.
22. Drucker DJ. Enhancing Incretin Action for the Treatment of Type 2 Diabetes. Diabetes Care. 2003;26(10):2929-2940. doi: 10.2337/diacare.26.10.2929.
23. Wang Y, Beydoun MA, Liang L, et al. Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic. Obesity. 2008;16(10):2323-2330. doi: 10.1038/oby.2008.351.
24. World Health Organization. On behalf of European Observatory on Health Systems, Observatory Studies Series № 19. Health in the European Union: Trends and Analysis, 2009. Available at: http://www.euro.who.int/observatory/Studies /20100201_1.
25. Zaninotto P, Head J, Stamatakis E, et al. Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. Journal of Epidemiology & Community Health. 2008;63(2):140-146. doi: 10.1136/jech.2008.077305.
Review
For citations:
Leskova I., Ermakov D., Matushevskaya E., Nishnianidze O. Socio-medical aspects of the normalization of body mass. Obesity and metabolism. 2016;13(4):49-52. (In Russ.) https://doi.org/10.14341/omet2016449-52
Views:
1691
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
